Genetic test to help pick antidepressant for teens
Part of Mental health clinical trials.
This study tests whether using a cheek swab DNA test can help choose a better antidepressant for teenagers with anxiety or depression. The goal is to see if this personalized approach leads to fewer side effects and better results.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Age 12 to 17 years old
- Has anxiety, depression, or both as the main problem
- Planning to start a new SSRI antidepressant
- Fluent in English
- No other major mental health conditions like OCD, bipolar disorder, eating disorder, autism, or psychosis
- No history of liver or blood stem cell transplant
- Never had the specific genetic test (CYP2B6, CYP2C19, CYP2D6) before
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies whether genes (using a saliva sample) can help explain why some young people feel more “disinhibited” after taking antidepressants like SSRIs. If you’ve had depression, anxiety, or OCD and have used an SSRI, your information and genetics may help improve how antidepressants are chosen and monitored.
This study tests whether using a genetic test can help doctors choose the most effective antidepressant for people with depression. The goal is to improve treatment outcomes and reduce side effects by tailoring the medication to your genetic makeup.
This study tests whether doing genetic testing before starting or adjusting antidepressants—guided by a pharmacist—can improve treatment for people with moderate to severe depression. The goal is to help match you with antidepressants more safely and effectively.
This trial tests whether using a website plus your genetic information helps doctors pick a better antidepressant for you. It aims to improve treatment for people with depression.
This study tests whether giving patients a genetic test before they start the antidepressant escitalopram can help doctors choose a safer and more effective dose. It is for people with unipolar depression, with or without anxiety, who have not taken this medication before.
This study looks for genetic and biological markers to help doctors choose the best depression treatment for each person. It aims to make treatment more personalized and effective.
Hear when a new Anxiety and Depression trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.